# Unleash Immuno Oncolytics jobs and careers

> 0 open roles at Unleash Immuno Oncolytics as of October 24, 2026. Source: https://www.thejobsmap.com/company/unleash-immuno-oncolytics

Unleash IO develops oncolytic immunotherapy products shown to be highly specific and efficacious in animal models and human tissue samples. Unleash IO’s leading product, UIO-512, is an oncolytic adenovirus that targets both malignant cells and tumor-associated stroma cells.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Headquarters | St. Louis, MO, United States |
| Founded | 2015 |
| Employees | 1 to 10 |
| Total funding | $3M |
| Industries | Biotechnology, Medical Device, Therapeutics |
| Website | https://unleash.bio |

## Leadership

- Daniel Katzman, CEO & Founder
- Imre (Imi) Kovesdi, Chief Scientific Officer

## Common questions

### Is Unleash Immuno Oncolytics hiring right now?

Unleash Immuno Oncolytics has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Unleash Immuno Oncolytics's careers site.

### Where is Unleash Immuno Oncolytics headquartered?

Unleash Immuno Oncolytics is headquartered in St. Louis, MO, United States and was founded in 2015.

### Who leads Unleash Immuno Oncolytics?

Daniel Katzman, CEO & Founder, is at the top of Unleash Immuno Oncolytics's org chart.

### How do I apply for a job at Unleash Immuno Oncolytics?

Pick a role on Unleash Immuno Oncolytics's TheJobsMap page and select Apply. Every listing links to the original posting on Unleash Immuno Oncolytics's own careers site, so you apply directly with the employer.